Children with AIDS

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The etiologic agent for acquired immune deficiency syndrome (AIDS) has been identified as human T lymphotropic virus type III (HTLV-III). Its distinguishing characteristics and putative receptor, the T4 molecule, are discussed. The Western Blot method has been applied to assess the presence of antibody HTLV-III in patients as a measure of infection with HTLV-III. The definition of AIDS in children, based on the Centers for Disease Control surveillance criteria, is explored and expanded. Clinical and laboratory manifestations of pediatric AIDS are explained in the context of 'HTLV-III infection' through an analysis of prospective and retrospective serologic studies. Transmission of the disease is explored through parental history of infected children. Finally, the rationale for antibody replacement therapy is set forth.

Original languageEnglish
Pages (from-to)33-38
Number of pages6
JournalVox Sanguinis
Volume51
Issue numberSUPPL. 2
StatePublished - Jan 1 1986
Externally publishedYes

Fingerprint

Acquired Immunodeficiency Syndrome
HIV Infections
Thyroid Hormone Receptors
HIV Antibodies
Centers for Disease Control and Prevention (U.S.)
Retrospective Studies
Western Blotting
HIV
Pediatrics
Antibodies
Therapeutics

ASJC Scopus subject areas

  • Hematology

Cite this

Pahwa, S. G. (1986). Children with AIDS. Vox Sanguinis, 51(SUPPL. 2), 33-38.

Children with AIDS. / Pahwa, Savita G.

In: Vox Sanguinis, Vol. 51, No. SUPPL. 2, 01.01.1986, p. 33-38.

Research output: Contribution to journalArticle

Pahwa, SG 1986, 'Children with AIDS', Vox Sanguinis, vol. 51, no. SUPPL. 2, pp. 33-38.
Pahwa SG. Children with AIDS. Vox Sanguinis. 1986 Jan 1;51(SUPPL. 2):33-38.
Pahwa, Savita G. / Children with AIDS. In: Vox Sanguinis. 1986 ; Vol. 51, No. SUPPL. 2. pp. 33-38.
@article{dc1a0a0235144c82bbf319c6ad89b48e,
title = "Children with AIDS",
abstract = "The etiologic agent for acquired immune deficiency syndrome (AIDS) has been identified as human T lymphotropic virus type III (HTLV-III). Its distinguishing characteristics and putative receptor, the T4 molecule, are discussed. The Western Blot method has been applied to assess the presence of antibody HTLV-III in patients as a measure of infection with HTLV-III. The definition of AIDS in children, based on the Centers for Disease Control surveillance criteria, is explored and expanded. Clinical and laboratory manifestations of pediatric AIDS are explained in the context of 'HTLV-III infection' through an analysis of prospective and retrospective serologic studies. Transmission of the disease is explored through parental history of infected children. Finally, the rationale for antibody replacement therapy is set forth.",
author = "Pahwa, {Savita G}",
year = "1986",
month = "1",
day = "1",
language = "English",
volume = "51",
pages = "33--38",
journal = "Vox Sanguinis",
issn = "0042-9007",
publisher = "Wiley-Blackwell",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Children with AIDS

AU - Pahwa, Savita G

PY - 1986/1/1

Y1 - 1986/1/1

N2 - The etiologic agent for acquired immune deficiency syndrome (AIDS) has been identified as human T lymphotropic virus type III (HTLV-III). Its distinguishing characteristics and putative receptor, the T4 molecule, are discussed. The Western Blot method has been applied to assess the presence of antibody HTLV-III in patients as a measure of infection with HTLV-III. The definition of AIDS in children, based on the Centers for Disease Control surveillance criteria, is explored and expanded. Clinical and laboratory manifestations of pediatric AIDS are explained in the context of 'HTLV-III infection' through an analysis of prospective and retrospective serologic studies. Transmission of the disease is explored through parental history of infected children. Finally, the rationale for antibody replacement therapy is set forth.

AB - The etiologic agent for acquired immune deficiency syndrome (AIDS) has been identified as human T lymphotropic virus type III (HTLV-III). Its distinguishing characteristics and putative receptor, the T4 molecule, are discussed. The Western Blot method has been applied to assess the presence of antibody HTLV-III in patients as a measure of infection with HTLV-III. The definition of AIDS in children, based on the Centers for Disease Control surveillance criteria, is explored and expanded. Clinical and laboratory manifestations of pediatric AIDS are explained in the context of 'HTLV-III infection' through an analysis of prospective and retrospective serologic studies. Transmission of the disease is explored through parental history of infected children. Finally, the rationale for antibody replacement therapy is set forth.

UR - http://www.scopus.com/inward/record.url?scp=0022508080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022508080&partnerID=8YFLogxK

M3 - Article

C2 - 2876550

AN - SCOPUS:0022508080

VL - 51

SP - 33

EP - 38

JO - Vox Sanguinis

JF - Vox Sanguinis

SN - 0042-9007

IS - SUPPL. 2

ER -